Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: men mailman who wrote (1046)	2/13/1998 12:02:00 PM
From: Patsy Collins	Respond to of 2068

You are right about the dilutive effect...

To: men mailman who wrote (1046)	2/13/1998 12:36:00 PM
From: Premier	Read Replies (1) \| Respond to of 2068

<<The way to figure this would be if 300 mil is 19% than 100% would=1578 plus 300=1878 total cap. An additional 19% of shares would be 15mil or total of 94 mil. 1878/94= $19.9 per share.>> In your computation 300MM is already included in 1578. You cannot add 300MM to it. Accordingly, per share value would be 1578/94=16.79. Now for the 300MM debt it does represent balance sheet deterioration and 300MM cash evaporating from Company assets to pay off $2 per share loss for 12/97 quarter and more writeoffs new management will take in 3/98 quarter. Therefore, based on your calculations you should not touch this stock over 13.75 which incidentally is low of this cycle. Best regards. Premier